1 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Recurrent Non-small Cell Lung Cancer: new trials by email Literature Review of Recurrent Non-small Cell Lung Cancer trials Research Report on Recurrent Non-small Cell Lung Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer paclitaxel, carboplatin, bevacizumab - Adenocarcinoma of the Lung, Bronchoalveolar Cell Lung Cancer | Phase 2 / Phase 3 | Completed | National Cancer Institute (NCI) | 842 | 2002-08-01 | 2013-02-27 |
Adenocarcinoma of Lung (1) · Adenocarcinoma, Bronchiolo-Alveolar (1) · Carcinoma, Non-Small-Cell Lung (1)
Adenocarcinoma (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Lung Diseases (1) · Lung Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1) · Thoracic Neoplasms (1)
Bevacizumab (1) · Carboplatin (1) · Paclitaxel (1) · Taxes (1)
National Cancer Institute (NCI) (1)
United States (1)
Alan Sandler (1)
U10CA021115 (1)